Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1956 1
1959 1
1964 2
1965 3
1967 2
1968 1
1969 1
1970 2
1971 1
1974 2
1975 2
1976 2
1978 1
1979 4
1980 3
1981 3
1982 1
1983 5
1984 13
1985 12
1986 8
1987 12
1988 7
1989 12
1990 16
1991 17
1992 13
1993 17
1994 19
1995 23
1996 23
1997 29
1998 34
1999 45
2000 45
2001 41
2002 67
2003 72
2004 107
2005 125
2006 142
2007 156
2008 165
2009 205
2010 249
2011 297
2012 319
2013 378
2014 432
2015 490
2016 514
2017 548
2018 619
2019 707
2020 818
2021 970
2022 1082
2023 1085
2024 304

Text availability

Article attribute

Article type

Publication date

Search Results

9,160 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Among authors: pan h. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
Xu J, Jiang H, Pan Y, Gu K, Cang S, Han L, Shu Y, Li J, Zhao J, Pan H, Luo S, Qin Y, Guo Q, Bai Y, Ling Y, Yang J, Yan Z, Yang L, Tang Y, He Y, Zhang L, Liang X, Niu Z, Zhang J, Mao Y, Guo Y, Peng B, Li Z, Liu Y, Wang Y, Zhou H; ORIENT-16 Investigators. Xu J, et al. Among authors: pan h. JAMA. 2023 Dec 5;330(21):2064-2074. doi: 10.1001/jama.2023.19918. JAMA. 2023. PMID: 38051328 Clinical Trial.
Immune cells and hypertension.
Gan L, Ye D, Feng Y, Pan H, Lu X, Wan J, Ye J. Gan L, et al. Among authors: pan h. Immunol Res. 2024 Feb;72(1):1-13. doi: 10.1007/s12026-023-09414-z. Epub 2023 Dec 4. Immunol Res. 2024. PMID: 38044398 Review.
TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.
Huang J, Pan H, Sun J, Wu J, Xuan Q, Wang J, Ke S, Lu S, Li Z, Feng Z, Hua Y, Yu Q, Yin B, Qian B, Zhou M, Xu Y, Bai M, Zhang Y, Wu Y, Ma Y, Jiang H, Dai W. Huang J, et al. Among authors: pan h. J Exp Clin Cancer Res. 2023 Oct 28;42(1):286. doi: 10.1186/s13046-023-02865-0. J Exp Clin Cancer Res. 2023. PMID: 37891677 Free PMC article.
Postoperative cognitive dysfunction-current research progress.
Zhao Q, Wan H, Pan H, Xu Y. Zhao Q, et al. Among authors: pan h. Front Behav Neurosci. 2024 Jan 30;18:1328790. doi: 10.3389/fnbeh.2024.1328790. eCollection 2024. Front Behav Neurosci. 2024. PMID: 38357422 Free PMC article. Review.
Immunogenic cell stress and death in the treatment of cancer.
Pan H, Liu P, Zhao L, Pan Y, Mao M, Kroemer G, Kepp O. Pan H, et al. Semin Cell Dev Biol. 2024 Mar 15;156:11-21. doi: 10.1016/j.semcdb.2023.10.007. Epub 2023 Nov 16. Semin Cell Dev Biol. 2024. PMID: 37977108 Review.
Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils.
Abskharon R, Pan H, Sawaya MR, Seidler PM, Olivares EJ, Chen Y, Murray KA, Zhang J, Lantz C, Bentzel M, Boyer DR, Cascio D, Nguyen BA, Hou K, Cheng X, Pardon E, Williams CK, Nana AL, Vinters HV, Spina S, Grinberg LT, Seeley WW, Steyaert J, Glabe CG, Ogorzalek Loo RR, Loo JA, Eisenberg DS. Abskharon R, et al. Among authors: pan h. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2300258120. doi: 10.1073/pnas.2300258120. Epub 2023 Oct 6. Proc Natl Acad Sci U S A. 2023. PMID: 37801475 Free PMC article.
9,160 results